About Us Locations Disclaimer

Dr. R. deGoma

Home
Prevention 2011
Who Needs Prevention
Benefits of Prevention
Risk Assessment
Advanced Lipid Therapy
Stent vs Medical Therapy
Specialized Center
Performance Data
Employer Mandate
Employee Prevention
Patient Mentoring
Coronary Calcium Score
Women & Heart Disease
NJPreventiveCardiology.com

 

Click here for NJ Preventive Cardiology practice brochure

 

Mentoring Program

The Million Hearts Initiative

For Physicians:

Practical Tips for Clinicians

For Communities:

Heart2Heart Talk

For Employers and Employees: You and Health Reform

     



Moving Science into Coverage

Heart attack and stroke: two manifestations of the same disease prcoess

Preventing one also prevents the other

Heart attack is the number 1 and stroke, number 3, causes of death and disability is the US. The underlying disease process is the same - atherosclerosis or simply, cholesterol plaque build up and subsequent rupture of the plaque.

The immediate cause of heart attack, stroke and sudden cardiac death is the sudden cessation of blood flow in the affected artery due to the rapid formation of a clot following plaque rupture.

Cholesterol plaque build up is a progressive and diffuse disease process that starts 10 to 30 years before the actual heart attack or stroke. Patients at risk can be identified early enough and treated effectively and safely.

Preventive treatment based on accumulated scientific advances in the last 15 years can directly alter the disease process itself. Over time, this treatment will first slow down the natural progression of the disease, then even halt its progression. And with optimal treatment, even cause disease regression. All of these effects cause plaque stabilization and prevention of plaque rupture and the consequences that follows.

Preventive treatment treats all arteries and all plaques regardless of their locations.

Benefits are seen within a few months and increase with time. After 2 to 5 years, optimal treatment  stops disease progression and in some cases, actually cause disease regression.

 

 

There is a direct relationship between the level of cardiovascular risk and the utilization of healthcare resources. The higher the risk, the greater the utilization of expensive healthcare resources. The lowest risk has the lowest utilization. Incentivizing employees at high risk like Jim by offering proven therapies that shifts them to a lower risk category will reduce the consumption of expensive cardiovascular healthcare resources. Evidence-based preventive medical therapy of high and very high risk population can significantly reduce cardiovascular risk and the need for stents, heart bypass surgeries, cardiac hospitalizations, etc... in addition to reducing death and disability from heart attack and stroke. Click about the magnitude of heart attack and stroke prevention possible.

Emil M. deGoma, MD, FACC

Medical Director,

UPenn Preventive Cardiovascular  Program

Health Premium Discount

Lower your risk for heart attack and stroke using evidence-based therapies and become eligible for a substantial premium discount by 2014.
Health Reform 2010
Prevention and Wellness Summary Provisions
Relay Health
Contact Office for Non-Urgent Matters

 

We Support Million Hearts Initiative

 

497,470 Preventable CHD Deaths Annually with Evidence-based Medical Therapy

 

JAMA: 38% of Nonacute Stents Called into Question

 

Optimal Medical Therapy Still Underused in CHD

 

Legacy Effects of Statin Therapy - Reduction in All-Cause Mortality

 

SG2 Expert Talks About Resetting Priorities in Cardiology

 

AHA: Get With The Guidelines - Not Much Improvement

 

AIM-HIGH Trial - Take Home Message

 

    
www.deGomaMD.com
Copyright 2001-2011     Preventing Most Heart Attacks and Strokes since 2001     eMedical Consulting     All rights reserved